These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 31277669)

  • 1. CRISPR-cas system: biological function in microbes and its use to treat antimicrobial resistant pathogens.
    Shabbir MAB; Shabbir MZ; Wu Q; Mahmood S; Sajid A; Maan MK; Ahmed S; Naveed U; Hao H; Yuan Z
    Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):21. PubMed ID: 31277669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CRISPR/Cas system as an antimicrobial resistance strategy in aquatic ecosystems.
    Gupta SS; Hamza Kh M; Sones CL; Zhang X; Sivaraman GK
    Funct Integr Genomics; 2024 May; 24(3):110. PubMed ID: 38806846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitizing pathogens to antibiotics using the CRISPR-Cas system.
    Goren M; Yosef I; Qimron U
    Drug Resist Updat; 2017 Jan; 30():1-6. PubMed ID: 28363331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugative Delivery of CRISPR-Cas9 for the Selective Depletion of Antibiotic-Resistant Enterococci.
    Rodrigues M; McBride SW; Hullahalli K; Palmer KL; Duerkop BA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31527030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Understanding the Molecular Mechanisms of Multidrug Resistance and Novel Approaches of CRISPR/Cas9-Based Genome-Editing to Combat This Health Emergency.
    Allemailem KS
    Int J Nanomedicine; 2024; 19():1125-1143. PubMed ID: 38344439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance.
    Rafiq MS; Shabbir MA; Raza A; Irshad S; Asghar A; Maan MK; Gondal MA; Hao H
    BioDrugs; 2024 May; 38(3):387-404. PubMed ID: 38605260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy.
    Yeh TK; Jean SS; Lee YL; Lu MC; Ko WC; Lin HJ; Liu PY; Hsueh PR
    Int J Antimicrob Agents; 2022 Jan; 59(1):106475. PubMed ID: 34767917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing prokaryotic clustered regularly interspaced short palindromic repeats-Cas adaptive immune system to combat antimicrobial resistance.
    Devi V; Harjai K; Chhibber S
    Future Microbiol; 2023 May; 18():443-459. PubMed ID: 37317864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future prospects for CRISPR-based tools in bacteria.
    Luo ML; Leenay RT; Beisel CL
    Biotechnol Bioeng; 2016 May; 113(5):930-43. PubMed ID: 26460902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in gene-editing approaches for tackling antibiotic resistance threats: a review.
    Al-Fadhli AH; Jamal WY
    Front Cell Infect Microbiol; 2024; 14():1410115. PubMed ID: 38994001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update.
    Bakhtiyari N; Farajnia S; Ghasemali S; Farajnia S; Pormohammad A; Saeidvafa S
    Infect Disord Drug Targets; 2024; 24(6):e260124226226. PubMed ID: 38284691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens.
    Ali Y; Inusa I; Sanghvi G; Mandaliya VB; Bishoyi AK
    Microb Pathog; 2023 Aug; 181():106199. PubMed ID: 37336428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resensitizing tigecycline- and colistin-resistant
    Zhang H; Chen B; Wang Z; Peng K; Liu Y; Wang Z
    Microbiol Spectr; 2024 Apr; 12(4):e0388423. PubMed ID: 38385691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative Delivery System Combining CRISPR-Cas12f for Combatting Antimicrobial Resistance in Gram-Negative Bacteria.
    Long TF; Zhou SY; Huang ZL; Li G; Zhong Q; Zhang XJ; Li YY; Chen CP; Xia LJ; Wei R; Wan L; Gao A; Ren H; Liao XP; Liu YH; Chen L; Sun J
    ACS Synth Biol; 2024 Jun; 13(6):1831-1841. PubMed ID: 38863339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance.
    Mayorga-Ramos A; Zúñiga-Miranda J; Carrera-Pacheco SE; Barba-Ostria C; Guamán LP
    ACS Infect Dis; 2023 Jul; 9(7):1283-1302. PubMed ID: 37347230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas system: a potential alternative tool to cope antibiotic resistance.
    Aslam B; Rasool M; Idris A; Muzammil S; Alvi RF; Khurshid M; Rasool MH; Zhang D; Ma Z; Baloch Z
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):131. PubMed ID: 32778162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome.
    Nath A; Bhattacharjee R; Nandi A; Sinha A; Kar S; Manoharan N; Mitra S; Mojumdar A; Panda PK; Patro S; Dutt A; Ahuja R; Verma SK; Suar M
    Biomed Pharmacother; 2022 Jul; 151():113122. PubMed ID: 35594718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified viruses deliver death to antibiotic-resistant bacteria.
    Reardon S
    Nature; 2017 Jun; 546(7660):586-587. PubMed ID: 28661508
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonviral Genome Editing Based on a Polymer-Derivatized CRISPR Nanocomplex for Targeting Bacterial Pathogens and Antibiotic Resistance.
    Kang YK; Kwon K; Ryu JS; Lee HN; Park C; Chung HJ
    Bioconjug Chem; 2017 Apr; 28(4):957-967. PubMed ID: 28215090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens.
    Saha U; Gondi R; Patil A; Saroj SD
    Mol Biotechnol; 2023 Jan; 65(1):1-16. PubMed ID: 35939207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.